2,537
Views
21
CrossRef citations to date
0
Altmetric
Articles

Stool Short-Chain Fatty Acids in Critically Ill Patients with Sepsis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 706-712 | Received 18 Sep 2019, Accepted 05 Feb 2020, Published online: 12 Mar 2020

References

  • Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041.
  • Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40(3):235–243. doi:10.1097/00004836-200603000-00015.
  • Yamada T, Shimizu K, Ogura H, Asahara T, Nomoto K, Yamakawa K, Hamasaki T, Nakahori Y, Ohnishi M, Kuwagata Y, et al. Rapid and sustained long-term decrease of fecal short-chain fatty acids in critically ill patients with systemic inflammatory response syndrome. JPEN J Parenter Enteral Nutr. 2015;39(5):569–577. doi:10.1177/0148607114529596.
  • Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness. Trends Mol Med. 2014;20(4):214–232. doi:10.1016/j.molmed.2013.08.004.
  • Cronin M, Ventura M, Fitzgerald GF, Van Sinderen D. Progress in genomics, metabolism and biotechnology of bifidobacteria. Int J Food Microbiol. 2011;149(1):4–18. doi:10.1016/j.ijfoodmicro.2011.01.019.
  • Suzuki T, Yoshida S, Hara H. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br J Nutr. 2008;100(2):297–305. doi:10.1017/S0007114508888733.
  • Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119. doi:10.1016/B978-0-12-800100-4.00003-9.
  • Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol. 2008;59:251–266.
  • Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003;73(13):1683–1690. doi:10.1016/S0024-3205(03)00490-9.
  • Vinolo MR, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3(10):858–876. doi:10.3390/nu3100858.
  • Shimizu K, Yamada T, Ogura H, Mohri T, Kiguchi T, Fujimi S, Asahara T, Yamada T, Ojima M, Ikeda M, et al. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial. Crit Care. 2018;22(1):239–248. doi:10.1186/s13054-018-2167-x.
  • Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Tasaki O, Matsushima A, Kuwagata Y, Shimazu T, Sugimoto H. Probiotic/synbiotic therapy for treating critically Ill patients from a gut microbiota perspective. Dig Dis Sci. 2013;58(1):23–32. doi:10.1007/s10620-012-2334-x.
  • Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagata Y, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60(1):126–133. doi:10.1097/01.ta.0000197374.99755.fe.
  • Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett. 2002;217(2):133–139. doi:10.1111/j.1574-6968.2002.tb11467.x.
  • O'Keefe SJD, Ou J, Delany JP, Curry S, Zoetendal E, Gaskins HR, Gunn S. Effect of fiber supplementation on the microbiota in critically ill patients. World J Gastrointest Pathophysiol. 2011;2(6):138–145. doi:10.4291/wjgp.v2.i6.138.
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J, Coopersmith CM, Hotchkiss R, et al. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287.
  • World Health Organization. Obesity: preventing and managing the global epidemic Report of a WHO Consultation (WHO Technical Report Series 894.). Geneva, Switzerland. World Health Organ Tech Rep Ser 2000.
  • Pan American Health Organization. Clinical guide for primary care for older adults. Module 5. Nutritional assessment of the elderly. Washington, DC: Pan American Health Organization - PAHO. 2002.
  • de la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, Velásquez-Mejía EP, Sierra JA, Corrales-Agudelo V, Carmona JA, Abad JM, Escobar JS. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients. 2019;11:1–16. doi:10.3390/nu11010051.
  • Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Nakahori Y, Osuka A, Yamano S, Goto M, Matsushima A, et al. Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study. Neurogastroenterol Motil. 2011;23(330–335):e157. doi:10.1111/j.1365-2982.2010.01653.x.
  • Hayakawa M, Asahara T, Henzan N, Murakami H, Yamamoto H, Mukai N, Minami Y, Sugano M, Kubota N, Uegaki S, et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci. 2011;56(8):2361–2365. doi:10.1007/s10620-011-1649-3.
  • Miquel S, Martín R, Rossi O, Bermúdez LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013;16(3):255–261. doi:10.1016/j.mib.2013.06.003.
  • Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005;71(7):3692–3700. doi:10.1128/AEM.71.7.3692-3700.2005.
  • Theriot CM, Bowman AA, Young VB. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for clostridium difficile spore germination and outgrowth in the large intestine. mSphere. 2016;1(1):1–16. doi:10.1128/mSphere.00045-15.
  • Guinan J, Wang S, Hazbun TR, Yadav H, Thangamani S. Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans. Sci Rep. 2019;9(1):8872. doi:10.1038/s41598-019-45467-7.
  • Konturek PC, Haziri D, Brzozowski T, Hess T, Heyman S, Kwiecien S, Konturek SJ, Koziel J. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J Physiol Pharmacol. 2015;66(4):483–491.
  • Valle Gottlieb MG, Closs VE, Junges VM, Schwanke C. Impact of human aging and modern lifestyle on gut microbiota. Crit Rev Food Sci Nutr. 2018;58(9):1557–1564. doi:10.1080/10408398.2016.1269054.
  • Załęski A, Banaszkiewicz A, Walkowiak J. Butyric acid in irritable bowel syndrome. Prz Gastroenterol. 2013;8:350–353. doi:10.5114/pg.2013.39917.
  • O’Keefe SJD. The need to reassess dietary fiber requirements in healthy and critically ill patients. Gastroenterol Clin North Am. 2018;47:219–229. doi:10.1016/j.gtc.2017.10.005.
  • Schneider SM, Girard-Pipau F, Filippi J, Hébuterne X, Moyse D, Hinojosa GC, Pompei A, Rampal P. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol. 2005;11(39):6165–6169. doi:10.3748/wjg.v11.i39.6165.
  • Majid H, Emery PW, Whelan K. Faecal microbiota and short-chain fatty acids in patients receiving enteral nutrition with standard or fructo-oligosaccharides and fibre-enriched formulas. J Hum Nutr Diet. 2011;24(3):260–268. doi:10.1111/j.1365-277X.2011.01154.x.